Microchip Technology Announces Financial Results for Third Quarter of Fiscal Year 2024
Net sales of $1.766 billion, down 21.7% sequentially and down 18.6% from the year ago quarter. Our preliminary net sales […]
Microchip Technology Increases Quarterly Cash Dividend 25.7% Year-Over-Year to 45.0 Cents Per Share
CHANDLER, Ariz., Feb. 01, 2024 (GLOBE NEWSWIRE) — (NASDAQ: MCHP) — Microchip Technology Incorporated, a leading provider of smart, connected, […]
Applied Optoelectronics Announces Date of Fourth Quarter and Full Year 2023 Financial Results Conference Call
SUGAR LAND, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access […]
The Ensign Group Reports Fiscal Year and Fourth Quarter 2023 Results; Issues 2024 Earnings Guidance
SAN JUAN CAPISTRANO, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of […]
TPI Composites, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
SCOTTSDALE, Ariz., Feb. 01, 2024 (GLOBE NEWSWIRE) — TPI Composites, Inc. (“TPI”) (Nasdaq: TPIC) today announced that the company will […]
Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
SAN CARLOS, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity […]
CNB Financial Corporation Announces Quarterly Dividend for Series A Preferred Stock and Related Depositary Shares Distribution
CLEARFIELD, Pa., Feb. 01, 2024 (GLOBE NEWSWIRE) — The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) (the “Corporation”) […]
seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting
BEVERLY, Mass. and REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — seqWell, a global provider of genomic library workflow […]
Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the […]
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a […]
